戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 an organic solvate to be trapped in a binary cocrystal.
2 ze the findings based upon an Abl-compound 1 cocrystal.
3 component combinations yielding at least one cocrystal.
4 actions to the GAC tertiary structure in the cocrystals.
5 ch for the development of responsive organic cocrystals.
6  C-I distance) in o-diiodotetrafluorobenzene cocrystals.
7 emonstration of THz spectroscopic imaging of cocrystals.
8  through X-ray analysis of the sugar-protein cocrystals.
9 apsulate C(70) and result in two-dimensional cocrystals.
10 ds, and in the manufacture of pharmaceutical cocrystals.
11                              Here, we report cocrystal and cryo-EM structures of Geobacillus kaustoph
12 copy allows quantitative chemical mapping of cocrystals and offers researchers and drug developers a
13                                          The cocrystals are composed of a tetratopic hydrogen-bond-ac
14                      Organic charge transfer cocrystals are inexpensive, modular, and solution-proces
15                                              Cocrystals are molecular complexes having crystal struct
16                                        These cocrystals are of considerable interest because of their
17 ature and strength of CT interactions in the cocrystal assembly.
18                                       AFM of cocrystals: Atomic force microscopy can be used to obser
19 nylphosphine, -arsine, and -stibine provides cocrystals based on I...P, I...As and I...Sb halogen bon
20 ility is observed for members of a series of cocrystals based on systematic changes to one cocrystal
21 is presented for the construction of ternary cocrystals, based on the orthogonality of two supramolec
22 ng attempts to produce novel two-dimensional cocrystals by coadsorbing components in a binary mixture
23 e by compressing a benzene-hexafluorobenzene cocrystal (CHCF), H-F-substituted graphane with a layere
24 R that could not be rationalized through the cocrystal complex, we sought to predict SAR through a QS
25 ocrystals based on systematic changes to one cocrystal component.
26                     Hollow organic molecular cocrystals comprised of 9-methylanthracene-1,2,4,5-tetra
27 tified using THz spectroscopic data, and the cocrystal concentration was calculated with 0.3-1.3% w/w
28             We report a remarkable system of cocrystals containing nicotinamide (NIC) and (R)-mandeli
29                       The formation of these cocrystals decreases energy but expands volume, in contr
30 it sharp peaks, enabling us to visualize the cocrystal distribution in nonuniform tablets.
31                                          The cocrystal distribution was clearly identified using THz
32                          Interestingly these cocrystals exhibited very diverse dielectric response in
33 y of 0.31 cm(2) V(-1) s(-1), and the 1-C(70) cocrystal exhibits ambipolar transport characteristics w
34                   Conversely, the DADP/TITNB cocrystal features impact sensitivity that is greatly re
35 imated the absolute binding constants) and a cocrystal featuring biaxial coordination of a diamide to
36 sion is general for the formation of all NIC cocrystals for which data exist (n = 40): +3.9 A(3)/mole
37                                         This cocrystal form was advanced to clinical development as a
38                             Instead, a novel cocrystal form with superior solubility was discovered a
39  halogen bonds sufficiently strong to enable cocrystal formation is an advance in supramolecular chem
40 se of excipients, particle coating, salt, or cocrystal formation.
41 e mechanisms and pathways of mechanochemical cocrystal formation.
42 ere we report supramolecular charge-transfer cocrystals formed by electron acceptor and donor molecul
43 lization and why some molecules are prolific cocrystal formers.
44 st, centimeter-long, organic charge transfer cocrystals have been grown by liquid-liquid diffusion un
45             Although the properties of these cocrystals have been investigated for decades, the princ
46          Six new binary charge-transfer (CT) cocrystals have been synthesized by solvent drop-assiste
47 ntial photobehavior of the pure crystals and cocrystals highlights the importance of TU in templating
48                                          The cocrystal includes the anionic [Ad(-)(HThy)] base pair w
49 able polymorph of the caffeine-glutaric acid cocrystal into the thermodynamically stable form was ana
50 s shown by colossal thermal expansion of the cocrystal involving I...Sb halogen bonds.
51 (GAC) of 23S ribosomal RNA (rRNA) as seen in cocrystals is extremely compact.
52  between relative module composition and the cocrystal lattice parameters.
53 bromobutadiyne, via topochemical reaction in cocrystals, leading to the ordered polymer poly(dibromod
54 mpact sensitivity of DADP is retained by the cocrystal, making it a denser and less volatile form of
55 nlike the crystal with virtual porosity, the cocrystal material remains single crystalline and porous
56          THz spectra of caffeine-oxalic acid cocrystal measured at low temperature exhibit sharp peak
57 s of two polycyclic 1:1 arene-perfluoroarene cocrystals, naphthalene/octafluoronaphthalene (NOFN) and
58 ay structuring supports the formation of the cocrystal of 5 with 3,5-diamino-1,2,4-triazole, which wa
59  report a structure at 2.8-A resolution of a cocrystal of a She2p tetramer bound to a segment of She3
60                        Analysis of the X-ray cocrystal of compound 51 bound to hGKRP revealed that th
61       Enzyme kinetics and the structure of a cocrystal of IRE1 complexed with ADP and quercetin revea
62                                            A cocrystal of PABC bound to LARP4 PAM2w shows tryptophan
63                                              Cocrystal of pamiparib shows similar binding sites with
64                                    Eight 2:1 cocrystals of amino acid zwitterions and Li(+) salts wer
65                                              Cocrystals of arachidonic acid and horse spleen apoferri
66                                              Cocrystals of both macro- and nanodimensions with highly
67 ution and X-ray crystallographic analysis of cocrystals of pyrene and NACs in the solid state indicat
68                                        While cocrystals of these eleven olefins photodimerized to a s
69                                  A series of cocrystals of three different diiodobenzene molecules an
70 44)][Thy].2H(2)O, as well as the double salt cocrystal, [P(4444)](2)[Ad][Thy].3H(2)O.2HThy.
71 ivity of a wide range of molecular and ionic cocrystals, pharmaceuticals, materials, and biomolecules
72         The noncentrosymmetric nature of the cocrystals, required to observe ferroelectric behavior,
73  data and the X-ray structure of the CR2-C3d cocrystal result in highest-scoring solutions in which C
74        The solid-state superstructure of the cocrystals reveals that a 2:1 ratio of acceptor to donor
75                  This dramatic difference in cocrystal sensitivities may stem from the significantly
76 nd strengths and solid-state properties, and cocrystal series such as that presented here provide a p
77                 We show components of binary cocrystal solvates to undergo an intermolecular photorea
78                                        X-ray cocrystal structural analysis revealed that the basis fo
79 c binding of norathyriol with ERK2 through a cocrystal structural analysis.
80  assay in combination with cellular and TLR8 cocrystal structural data resulted in the identification
81                                NMR and X-ray cocrystal structural studies provided more structural in
82 odel for Machupo virus, for which a suitable cocrystal structural template exists.
83           Here we report the high-resolution cocrystal structure (1.5 angstrom) of the DENV-2 capsid
84              The E. faecalis mvaS-hymeglusin cocrystal structure (1.95 A) reveals virtually complete
85                                         This cocrystal structure allowed the design of a covalent inh
86 ctivity relationship (SAR) studies and X-ray cocrystal structure analysis allowed a detailed assessme
87                                     An X-ray cocrystal structure and a refined binding model allowed
88                                     An X-ray cocrystal structure and SAR study revealed the ability o
89  to BRPF1B was rationalized through an X-ray cocrystal structure determination, which showed a flippe
90        Conversely, the phosphomimetic mutant cocrystal structure disclosed an alternative arrangement
91                                          The cocrystal structure for one of these antibodies, D25, in
92        Modeling onto a CYT-18/group I intron cocrystal structure indicates that the C-terminal domain
93                           Our PptT-inhibitor cocrystal structure may aid further development of antim
94  site on CR2 have indicated that the CR2-C3d cocrystal structure may represent an encounter/intermedi
95                              On the basis of cocrystal structure of 1 in human PDE10A enzyme, we desi
96                                    The X-ray cocrystal structure of 1 with the ALK kinase domain reve
97                                          The cocrystal structure of 10 with MDM2 inspired two indepen
98     With the aid of an unphosphorylated Akt1 cocrystal structure of 12j solved at 2.25 A, it was poss
99                         We have determined a cocrystal structure of 18 in complex with BRD4 BD2 at 1.
100                                              Cocrystal structure of 26 in PDE10A confirmed the bindin
101 vel interactions with L92/L94 confirmed by a cocrystal structure of 27 with BRD4.
102                                          The cocrystal structure of 3 (PHA-665752), bound to c-MET ki
103                         Determination of the cocrystal structure of 31 with BRD4 BD2 provides a struc
104                                          The cocrystal structure of 45 in complex with human BRD4 BD1
105                                Guided by the cocrystal structure of 5, SAR exploration revealed that
106 esis of new cathepsin B inhibitors using the cocrystal structure of 5-nitro-8-hydroxyquinoline in the
107                                   Although a cocrystal structure of a complex between C3d and the lig
108              We report the 2.05-A resolution cocrystal structure of a complex of BioH with pimeloyl-A
109                             As revealed by a cocrystal structure of a core MOBKL1B-NS5A peptide compl
110                              We now report a cocrystal structure of a CR2(SCR1-2):C3d complex at 3.2
111 or 2 (TLR2), were designed making use of the cocrystal structure of a TLR2 heterodimer (with TLR1) wi
112 for inhibitor interaction, we determined the cocrystal structure of ABL2 with the oncology drug imati
113                                     With the cocrystal structure of an advanced ligand in this novel
114                          Here we present the cocrystal structure of an engineered thermostable varian
115                         The 2.2 A resolution cocrystal structure of an inactive variant in complex wi
116 e oligomeric ligand:NP complex, and an X-ray cocrystal structure of an NP dimer of trimers (or hexame
117                                          The cocrystal structure of antibody 10E8v4 with its HIV-1 ep
118                                We report the cocrystal structure of bacteriophage N15 Cro with a symm
119                                          The cocrystal structure of CAP257-RH1 bound to RHPA gp120 re
120                       Here, we determine the cocrystal structure of chicken ASIC1a with MitTx, a pain
121                          Guided by the X-ray cocrystal structure of compound 1 bound to hGKRP, we ide
122                               Furthermore, a cocrystal structure of compound 24 complexed to TNKS1 de
123 d were prepared taking advantage of an X-ray cocrystal structure of compound 5 with GSK-3beta.
124                                          The cocrystal structure of CR2 with its ligand C3d provides
125 he active site of the enzyme, as seen in the cocrystal structure of derivative 31 with the homodimeri
126 the ones reported for 1) the high resolution cocrystal structure of epothilone A with an alpha,beta-t
127 d as an irreversible covalent inhibitor, the cocrystal structure of FAAH complexed with compound 2 re
128                           We here report the cocrystal structure of FKBP51 with a simplified alpha-ke
129 l structure of the G9a-10 complex, the first cocrystal structure of G9a with a small molecule inhibit
130                                            A cocrystal structure of HDAC6 complexed with NR-160 discl
131                                      A 2.9 A cocrystal structure of JAK3 in complex with 9 confirms t
132                                          The cocrystal structure of LL320 confirms its interaction wi
133                                              Cocrystal structure of meningococcal factor H binding pr
134                                          The cocrystal structure of Mer with two compounds (7 and 22)
135                                          The cocrystal structure of NBD-11021 complexed to a monomeri
136                    We solved a 2.25 angstrom cocrystal structure of one DAC helical peptide bound to
137                                        A UTP cocrystal structure of one mutant shows, in contrast to
138                     Importantly, we report a cocrystal structure of one of our compounds (29c) bound
139 rther understand the mode of inhibition, the cocrystal structure of one of the most promising candida
140                                          The cocrystal structure of one of these compounds with caspa
141                                            A cocrystal structure of one such inhibitor reveals specif
142 s enabled the acquisition of the first X-ray cocrystal structure of p110beta with the selective inhib
143                       In a previous study, a cocrystal structure of PPARgamma bound to 2-chloro-N-(3-
144                                   Based on a cocrystal structure of PRMT6-MS023 (a type I PRMT inhibi
145                          On the basis of the cocrystal structure of RAP1/TRF2 complex, we have develo
146 d with wild type MDD, as judged by the 2.1 A cocrystal structure of S192A with FMVAPP.
147 nto inhibition of MPO by SPIN, we solved the cocrystal structure of SPIN bound to a recombinant form
148 HF three-dimensional structure, based on the cocrystal structure of Streptomyces coelicolor IHF duple
149                                            A cocrystal structure of T338C c-Src with a vinylsulfonami
150                                      A 2.4 A cocrystal structure of TAK1 in complex with 1 confirms t
151                                          The cocrystal structure of the 1918 hemagglutinin with 2D1,
152                             In this study, a cocrystal structure of the acetylcholine binding protein
153                                     With the cocrystal structure of the best ligand in this novel ser
154 h a previously reported small molecule X-ray cocrystal structure of the Jak1 kinase domain, provided
155                                            A cocrystal structure of the ligand-binding domain of ERRa
156                             We determine the cocrystal structure of the MeCP2 NID in complex with the
157                                       In the cocrystal structure of the mutated Ls-AChBP with the hig
158                                          The cocrystal structure of the NiV W:14-3-3 complex, as only
159              Here, we report a 2.8- angstrom cocrystal structure of the Nocardia farcinica ileS T-box
160                          We report the 1.8-A cocrystal structure of the PksA PT domain from aflatoxin
161 conformational change in GlpG by solving the cocrystal structure of the protease with a mechanism-bas
162                                          The cocrystal structure of the related oxindole hydrazide c-
163                                            A cocrystal structure of the SAR405838:MDM2 complex shows
164                                          The cocrystal structure of the W C-terminal binding motif wi
165 omain of 10 amino acids in TRPM3 and solve a cocrystal structure of this domain together with Gbetaga
166                                          The cocrystal structure of this enzyme with a transition sta
167 scopy and is complemented by a comprehensive cocrystal structure prediction methodology that surpasse
168                 The native nonphosphorylated cocrystal structure revealed an inactive dimer in which
169                               A 1.8-angstrom cocrystal structure revealed that SR-717 functions as a
170                                      A 2.0 A cocrystal structure revealed the inhibitor to be the acy
171                                The resulting cocrystal structure revealed the specific ligand-protein
172 petitive with acetyl coenzyme A and an X-ray cocrystal structure reveals that binding is biased towar
173       A high-resolution 1.18- angstrom X-ray cocrystal structure shows that the compound binds to a w
174                          The recent CcrM-DNA cocrystal structure shows the CcrM dimer disrupts four o
175                                          The cocrystal structure to 2.0-A resolution of this N-termin
176          We determine the acetylcholine-ELIC cocrystal structure to a 2.9-A resolution and find that
177                               A ligand-bound cocrystal structure was determined which elucidated key
178                                  The Nampt-7 cocrystal structure was subsequently obtained and enable
179  derivative of 4-aminophenylalanine, and its cocrystal structure with gp120 revealed the cyclohexane
180                                            A cocrystal structure with one of these compounds and ATX
181 ty relationships and a high resolution X-ray cocrystal structure with West Nile virus protease provid
182  the first described potentiator-bound X-ray cocrystal structure within this class of ligand-gated io
183                      In the AcrB/doxorubicin cocrystal structure, binding of three doxorubicin molecu
184  of the structural insights revealed by this cocrystal structure, optimization of the 7-dimethylamino
185 vinblastine C20' center depicted in an X-ray cocrystal structure, remarkably large C20' urea derivati
186        We also solved the peptide:alpha-Cbtx cocrystal structure, revealing that the peptide, althoug
187 yltransferase in Pseudomonas aeruginosa This cocrystal structure, together with the structure of free
188  developed a more potent analog and solved a cocrystal structure, which is the first crystal structur
189  previously published results and the RT-EFV cocrystal structure.
190 t halogen-peroxide interactions seen in each cocrystal structure.
191 obtain the first human PARG substrate-enzyme cocrystal structure.
192  N terminus of MEKK3, and determine a 2.35 A cocrystal structure.
193 ss spectrometry and kinetic studies and by a cocrystal structure.
194                                     Two LovC cocrystal structures and enzymological studies help eluc
195                                  Analyses of cocrystal structures and molecular dynamics simulations
196                                              Cocrystal structures and molecular dynamics simulations
197                                              Cocrystal structures at atomic resolution revealed that
198                  Finally, on the basis of 11 cocrystal structures bound to CDK9/cyclin T or CDK2/cycl
199                                              Cocrystal structures corroborated the docking prediction
200                              High-resolution cocrystal structures delineated a unique ligand-binding
201 ) and leveraging insights from several X-ray cocrystal structures during optimization efforts.
202 ular details of the interactions revealed by cocrystal structures efficiently describe the properties
203    Additionally, we obtained high-resolution cocrystal structures for a majority of the compounds.
204 del that was trained on all antibody-antigen cocrystal structures in the Protein Data Bank.
205 his observation can be rationalized based on cocrystal structures of (R)-4 and (R)-7 bound to acetylc
206                                          The cocrystal structures of (S)-37 and (R)-38 showed similar
207 l information derived from PI3K gamma-ligand cocrystal structures of 1 and 2 were used to design inhi
208                                              Cocrystal structures of 16 and 18 complexed with WDR5 pr
209                                              Cocrystal structures of 20by with both PARP-1 and PARP-2
210                                        X-ray cocrystal structures of 8 and 19 bound to the Jak2 kinas
211                                We report the cocrystal structures of a computationally designed and e
212 he structure-activity relationship (SAR) and cocrystal structures of a series of Nek2 inhibitors deri
213                              Analysis of the cocrystal structures of an initial lead 8 prompted us to
214                     Here, we present several cocrystal structures of BjaI, a CoA-dependent LuxI homol
215                                        Novel cocrystal structures of BRD7 liganded with new and previ
216 tructure-based design was performed using 35 cocrystal structures of CDK2 liganded with distinct anal
217  enzymes efficiently remove NAD(+) caps, and cocrystal structures of DXO/Rai1 with 3'-NADP(+) illumin
218                                              Cocrystal structures of EphB3 in complex with two quinaz
219                                              Cocrystal structures of Escherichia coli RNA polymerase
220                                          The cocrystal structures of GLP and G9a in the complex with
221                     We report here the first cocrystal structures of gyrase B bound to coumermycin A1
222                          Here we present two cocrystal structures of human SerRS bound with tRNA(Sec)
223 tanding of these determinants, we determined cocrystal structures of Imatinib and Sorafenib with p38a
224   Subsequent hit-to-lead optimization, using cocrystal structures of inhibitors bound to Pseudomonas
225                                              Cocrystal structures of inhibitors with wild-type HIV-1
226                                        X-ray cocrystal structures of key compounds with XIAP BIR2 sug
227                                   We present cocrystal structures of KRIT1 with ICAP1 and ICAP1 with
228                                              Cocrystal structures of mesotrypsin with HAI2 and bikuni
229                                   We present cocrystal structures of murine TTLL6 bound to tetrahedra
230 hesis, structure-activity relationships, and cocrystal structures of novel derivatives of the competi
231     We also report the high-resolution X-ray cocrystal structures of NV 3CLpro-, poliovirus 3Cpro-, a
232 s conclusion is based on binding studies and cocrystal structures of PHD(UHRF1) bound to histone H3 p
233                                              Cocrystal structures of potent inhibitors with PvSHMT we
234 s are known to interact with CL, and several cocrystal structures of protein-CL complexes exist.
235  during our hit to lead campaign, along with cocrystal structures of representatives with Mtb TMK.
236                                              Cocrystal structures of several new derivatives helped i
237 structure-activity relationship studies, and cocrystal structures of the 18 hit compounds were analyz
238                                     Previous cocrystal structures of the 58-nucleotide GAC RNA bound
239                                    The X-ray cocrystal structures of the early lead compound 12 and c
240                         Here, we report five cocrystal structures of the enzyme complexed with both a
241                              We solved X-ray cocrystal structures of the highest affinity binders fro
242                              Recently solved cocrystal structures of the MV attachment protein (hemag
243   Here we disclose the first high resolution cocrystal structures of the P. aeruginosa PBP3 with both
244  of individual residues and two 1.5 angstrom cocrystal structures of the tightest-binding mutants in
245 +) (1.7 A resolution), as well as four other cocrystal structures of thermostable PTDH and its varian
246                                              Cocrystal structures of these macrocyclic natural produc
247  transfer difference (STD) NMR and the first cocrystal structures of two potent in vitro inhibitors,
248 e apo crystal structure of WhiE ARO/CYC, and cocrystal structures of WhiE and TcmN ARO/CYCs bound wit
249 alytic cleft of all 1252 human kinase-ligand cocrystal structures present in the Protein Data Bank (P
250 iterative parallel synthesis guided by X-ray cocrystal structures resulted in rapid potency improveme
251 ce differences exceeding 50%, antibody-gp120 cocrystal structures reveal VRC01-class recognition to b
252                                              Cocrystal structures revealed 3 binds to an unexpected a
253                                Intriguingly, cocrystal structures revealed an unexpected inverted bin
254                                              Cocrystal structures revealed binding modes of RVX-208 a
255                                        X-ray cocrystal structures revealed that the K9M residue of hi
256 dies reveal a nonlinear SAR for Nek2 and our cocrystal structures show that compounds in this series
257                                              Cocrystal structures show that, in addition to electrost
258                                              Cocrystal structures showed that PFI-1 acts as an acetyl
259                                              Cocrystal structures suggest that the orthologous part o
260 nes and related compounds in published X-ray cocrystal structures were analyzed.
261                        High-resolution X-ray cocrystal structures were used to optimize the structure
262                                   1.35 A TAT cocrystal structures with bisubstrate analogs constrain
263                                              Cocrystal structures with H1 and H5 HAs reveal that the
264                 Here, we describe the use of cocrystal structures with inhibitors and substrates, alo
265 re-based design was guided by several solved cocrystal structures with Mcl-1, leading to the developm
266                                     Five new cocrystal structures with PvSHMT were solved at 2.3-2.6
267  different conformations in their respective cocrystal structures with RNA polymerase, reflecting its
268                                Comparison of cocrystal structures with structure-activity relationshi
269                      In addition, auristatin cocrystal structures with tubulin are being presented th
270 f known TRK inhibitors and analysis of their cocrystal structures, (3) an overview of TRK clinical tr
271 with assay results, docking simulations, and cocrystal structures, a model for stereochemical control
272                              Guided by X-ray cocrystal structures, fragment 1 was elaborated into a n
273 rom ATP to dTMP, was proposed based on X-ray cocrystal structures, homology models, and structure-act
274 imarily focused on obtaining ligand-receptor cocrystal structures, recent studies implicate an import
275                                    Guided by cocrystal structures, we elaborated arylsulfonyl fluorid
276 based drug design based on a number of X-ray cocrystal structures, we morphed this hit class into pot
277 series based on multiple ligand/KDM1A-CoRest cocrystal structures, which led to several extremely pot
278 unresolved in all five MeV H-head crystal or cocrystal structures.
279 s, which is stabilized by the L11 protein in cocrystal structures.
280  rationalized on the basis of multiple X-ray cocrystal structures.
281 m the first bona fide human immunoproteasome cocrystal structures.
282 nhibitors through the iterative use of X-ray cocrystal structures.
283 g into the previously disclosed 3-CRBN-GSPT1 cocrystal ternary complex.
284 emonstrating for the first time an energetic cocrystal that is less sensitive to impact than either o
285  by imaging in the microscope an amyloid-dye cocrystal that, upon excitation, converts light into mec
286  a strategy directed toward the design of CT cocrystals that allows us to introduce rotational dynami
287  between the building blocks leads to binary cocrystals that have alternating donors and acceptors ex
288 re we report a series of energetic-energetic cocrystals that incorporate the primary explosive diacet
289 rmolecular photoreaction to generate ternary cocrystals that results in release of entrapped solvent
290 g sensitivity, in the case of the DADP/TCTNB cocrystal, the high impact sensitivity of DADP is retain
291                            In the enzyme-DNA cocrystal, the single catalytic site binds two magnesium
292 molecular dynamics at the atomistic scale in cocrystals, thereby displaying high permittivity.
293            The final form, a phosphoric acid cocrystal, was produced in high yield and purity and wit
294                                    Strong CT cocrystals were found to display a rigid supramolecular
295    Another brick in the wall: Porous ternary cocrystals were prepared by chiral recognition between o
296 ependent kinases (CDKs) 2, 5, and 9, and the cocrystal with CDK2/cyclin A2 revealed its binding in th
297 tion of an isocoumarin to generate a ternary cocrystal with cyclobutane molecules that support guest
298 to -18 degrees C), dibromobutadiyne can form cocrystals with oxalamide host molecules containing eith
299                                          The cocrystals with the bis(nitrile) oxalamide host undergo
300 ime-dependent noncompetitive inhibition, the cocrystal X-ray structure of 3 bound to a humanized vari

 
Page Top